Alnylam Pharmaceuticals Inc Virtual R&D Day Transcript
The R&D Day 2021. I'm Christine Lindenboom, Senior Vice President of Investor Relations and Corporate Communications, and we are very pleased that you've turned in to hear about progress across our portfolio. As you can see, we have a very exciting lineup of presentations scheduled during our time together, spanning the breadth of our pipeline, from our TTR franchise, to progress with zilebesiran as a potential treatment for hypertension, to our R&D efforts beyond the liver and what we have percolating in the next wave of our R&D engine before we close with an update on our progress towards P5x25.
A few quick reminders before we dive in. This event is scheduled to run until 1:00 p.m. And we've incorporated a break into the agenda. We'll be hosting 2 live moderated Q&A sessions during the meeting. To ask a question, please type your question into the Q&A box on your screen. A replay of today's session will be available on the Investor page of our website later today.
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
